Current opinion in nephrology and hypertension

Keyphrases

Publications

volume 33, number 4, 2024

Guillaume Courbon, Valentin David
Fibroblast growth factor 23 is pumping iron: C-terminal-fibroblast growth factor 23 cleaved peptide and its function in iron metabolism. Current opinion in nephrology and hypertension 33 (4) (2024)
Anna Faivre, Sophie de Seigneux
The role of hypoxia in chronic kidney disease: a nuanced perspective. Current opinion in nephrology and hypertension 33 (4) (2024)
Pieter Evenepoel, Hanne Skou Jørgensen
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Matteo Bargagli, Sven Trelle, Olivier Bonny, Daniel G Fuster
Thiazides for kidney stone recurrence prevention. Current opinion in nephrology and hypertension 33 (4) (2024)
Tyrone G Harrison, Meghan J Elliott, Marcello Tonelli
Integrating the patient voice: patient-centred and equitable clinical risk prediction for kidney health and disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Barbara Cellini
A molecular journey on the pathogenesis of primary hyperoxaluria. Current opinion in nephrology and hypertension 33 (4) (2024)
Henrik Dimke
New insights into renal calcium-sensing receptor activation. Current opinion in nephrology and hypertension 33 (4) (2024)
Matteo Bargagli, Sven Trelle, Olivier Bonny, Daniel G Fuster
Thiazides for kidney stone recurrence prevention. Current opinion in nephrology and hypertension 33 (4) (2024)
Barbara Cellini
A molecular journey on the pathogenesis of primary hyperoxaluria. Current opinion in nephrology and hypertension 33 (4) (2024)
Sharon Huish, Smeeta Sinha
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Lashodya V Dissanayake, Oleg Palygin, Alexander Staruschenko
Lysine and salt-sensitive hypertension. Current opinion in nephrology and hypertension 33 (4) (2024)
Lashodya V Dissanayake, Oleg Palygin, Alexander Staruschenko
Lysine and salt-sensitive hypertension. Current opinion in nephrology and hypertension 33 (4) (2024)
Xian Liao, Emilia Scheidereit, Christoph Kuppe
New tools to study renal fibrogenesis. Current opinion in nephrology and hypertension 33 (4) (2024)
Jakob Höppner, Harald Jüppner
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays. Current opinion in nephrology and hypertension 33 (4) (2024)
Anna Faivre, Sophie de Seigneux
The role of hypoxia in chronic kidney disease: a nuanced perspective. Current opinion in nephrology and hypertension 33 (4) (2024)
Christoph Zechner, Eugene P Rhee
Phosphate sensing in health and disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Sharon Huish, Smeeta Sinha
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Orly Tabachnikov, Karl Skorecki, Etty Kruzel-Davila
APOL1 nephropathy - a population genetics success story. Current opinion in nephrology and hypertension 33 (4) (2024)
Matteo Bargagli, Sven Trelle, Olivier Bonny, Daniel G Fuster
Thiazides for kidney stone recurrence prevention. Current opinion in nephrology and hypertension 33 (4) (2024)
Yong-Yao W Cheng, Chih-Jen Cheng
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism. Current opinion in nephrology and hypertension 33 (4) (2024)
Orly Tabachnikov, Karl Skorecki, Etty Kruzel-Davila
APOL1 nephropathy - a population genetics success story. Current opinion in nephrology and hypertension 33 (4) (2024)
Yong-Yao W Cheng, Chih-Jen Cheng
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism. Current opinion in nephrology and hypertension 33 (4) (2024)
Xian Liao, Emilia Scheidereit, Christoph Kuppe
New tools to study renal fibrogenesis. Current opinion in nephrology and hypertension 33 (4) (2024)
Anna Faivre, Sophie de Seigneux
The role of hypoxia in chronic kidney disease: a nuanced perspective. Current opinion in nephrology and hypertension 33 (4) (2024)
Orly Tabachnikov, Karl Skorecki, Etty Kruzel-Davila
APOL1 nephropathy - a population genetics success story. Current opinion in nephrology and hypertension 33 (4) (2024)
Orly Tabachnikov, Karl Skorecki, Etty Kruzel-Davila
APOL1 nephropathy - a population genetics success story. Current opinion in nephrology and hypertension 33 (4) (2024)
Pieter Evenepoel, Hanne Skou Jørgensen
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease. Current opinion in nephrology and hypertension 33 (4) (2024)
Christoph Zechner, Eugene P Rhee
Phosphate sensing in health and disease. Current opinion in nephrology and hypertension 33 (4) (2024)

volume 33, number 5, 2024

John Demko, Robert Weber, David Pearce, Bidisha Saha
Aldosterone-independent regulation of K + secretion in the distal nephron. Current opinion in nephrology and hypertension 33 (5) (2024)
Marcelle Tuttle, Mark J Sarnak, Sankar D Navaneethan
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Joshua S Carty, Jason A Watts, Juan Pablo Arroyo
Vasopressin, protein metabolism, and water conservation. Current opinion in nephrology and hypertension 33 (5) (2024)
Raghunandan Konda, Arun Rajasekaran, Dana V Rizk
Antineutrophil cytoplasmic antibody-associated vasculitis. Current opinion in nephrology and hypertension 33 (5) (2024)
Yi-Jing G Cheng, Chien-Chou Chen, Chih-Jen Cheng
Postnatal renal tubule development: roles of tubular flow and flux. Current opinion in nephrology and hypertension 33 (5) (2024)
John Demko, Robert Weber, David Pearce, Bidisha Saha
Aldosterone-independent regulation of K + secretion in the distal nephron. Current opinion in nephrology and hypertension 33 (5) (2024)
Marcelle Tuttle, Mark J Sarnak, Sankar D Navaneethan
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Yi-Jing G Cheng, Chien-Chou Chen, Chih-Jen Cheng
Postnatal renal tubule development: roles of tubular flow and flux. Current opinion in nephrology and hypertension 33 (5) (2024)
Mythri Shankar, Sehrish Ali, Silvi Shah
Women's health and kidney protective medications. Current opinion in nephrology and hypertension 33 (5) (2024)
John Danziger
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Mythri Shankar, Sehrish Ali, Silvi Shah
Women's health and kidney protective medications. Current opinion in nephrology and hypertension 33 (5) (2024)
Arnold Tsamo Tetou, Dorothee Günzel
The role of claudins in renal transepithelial transport and kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Joshua S Carty, Jason A Watts, Juan Pablo Arroyo
Vasopressin, protein metabolism, and water conservation. Current opinion in nephrology and hypertension 33 (5) (2024)
Ittamar Gork, Fei Xiong, Abhijat Kitchlu
Cancer drugs and acute kidney injury: new therapies and new challenges. Current opinion in nephrology and hypertension 33 (5) (2024)
Joshua S Carty, Jason A Watts, Juan Pablo Arroyo
Vasopressin, protein metabolism, and water conservation. Current opinion in nephrology and hypertension 33 (5) (2024)
Shweta Bansal
Revisiting resistant hypertension in kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Yi-Jing G Cheng, Chien-Chou Chen, Chih-Jen Cheng
Postnatal renal tubule development: roles of tubular flow and flux. Current opinion in nephrology and hypertension 33 (5) (2024)
Shweta Bansal
Revisiting resistant hypertension in kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
John Demko, Robert Weber, David Pearce, Bidisha Saha
Aldosterone-independent regulation of K + secretion in the distal nephron. Current opinion in nephrology and hypertension 33 (5) (2024)
Marcelle Tuttle, Mark J Sarnak, Sankar D Navaneethan
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Shweta Bansal
Revisiting resistant hypertension in kidney disease. Current opinion in nephrology and hypertension 33 (5) (2024)
Mythri Shankar, Sehrish Ali, Silvi Shah
Women's health and kidney protective medications. Current opinion in nephrology and hypertension 33 (5) (2024)